This is an old revision of this page, as edited by Beetstra (talk | contribs) at 15:12, 17 November 2011 (Saving copy of the {{drugbox}} taken from revid 450475378 of page Gatifloxacin for the Chem/Drugbox validation project (updated: 'DrugBank').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:12, 17 November 2011 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 450475378 of page Gatifloxacin for the Chem/Drugbox validation project (updated: 'DrugBank').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This page contains a copy of the infobox ({{drugbox}}) taken from revid 450475378 of page Gatifloxacin with values updated to verified values. |
Clinical data | |
---|---|
Trade names | Zymar |
AHFS/Drugs.com | Monograph |
MedlinePlus | a605012 |
Routes of administration | Oral (discontinued), Intravenous (discontinued) ophthalmic |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 20% |
Elimination half-life | 7 to 14 hours |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C19H22FN3O4 |
Molar mass | 375.394 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |